Kuala Lumpur APRIL 30, 2018 – Handicraft made with love by children with autism will be showcased throughout Malaysia, thanks to Champs, Malaysia’s largest vitamin brand for children which is collaborating with the National Autism Society of Malaysia (NASOM) to create greater awareness and acceptance of autism, besides enabling the latter’s products to be appreciated by a wider market.
Kuala Lumpur April 25, 2018 – CCM Duopharma Biotech Berhad (CCM Duopharma) has raised RM5,000 in funds, through its “Wear Green for Charity” campaign, for the MAA Medicare Charitable Foundation which offers subsidised dialysis treatment to needy patients who are suffering from chronic kidney disease.
Bangi APRIL 3, 2018 – CCM Duopharma Biotech Berhad (Duopharma) expects its newly completed Effervescent plant in Bangi, the country’s first ever such facility, to put the Company at the forefront of technology development in manufacturing high-quality pharmaceutical products using Effervescent technology that offers advantages over conventional manufacturing of healthcare products.
Kuala Lumpur – Popularity of CCM Duopharma Biotech Berhad (Duopharma) sponsored drama series titled ‘Lafazkan Kalimah Cintamu’ has boosted sales of Flavettes Effervescent significantly due to the drama’s high rating and trending on the social media recently.
Bangi, Selangor – CCM Duopharma Biotech Berhad’s (Duopharma) effort in intensifying its Halal integrity in the Halal pharmaceutical sector was further endorsed via the visit of Datuk Dr. Zulkifli Bin Mohamad Al-Bakri, Mufti of the Federal Territory, to its manufacturing plant located in Bangi recently.
Kuala Lumpur, February 27 2018 – CCM Duopharma Biotech Berhad (Duopharma) has proposed a bonus issue of up to 371,945,333 new ordinary shares on the basis of four (04) bonus shares for every three (03) existing shares, reflecting the company’s stronger fundamentals after it completed its demerger exercise earlier this year. Its Group Managing Director, Leonard Ariff Abdul Shatar said the bonus issue is aimed at rewarding existing shareholders for their loyalty and continuous support as well as increasing the share capital of the company to a level that will better reflect the current scale of operations and assets employed by Duopharma and its subsidiaries. In the statement to the local bourse today, Duopharma also announced that it is declaring its final dividend of six (06) sen per share and the Company is proposing to undertake the Proposed Dividend Reinvestment Plan (DRP), whereby the shareholders will be given the option to elect to reinvest the whole or part of the dividend into new ordinary shares of Duopharma.
Kuala Lumpur, February 27 2018 – CCM Duopharma Biotech Berhad (Duopharma) has proposed a bonus issue of up to 371,945,333 new ordinary shares on the basis of four (04) bonus shares for every three (03) existing shares, reflecting the company’s stronger fundamentals after it completed its demerger exercise earlier this year.
Kuala Lumpur – CCM Duopharma Biotech Berhad (CCMD) has entered into a collaboration with Natco Pharma Ltd of India to commercialise a range of Hepatitis C products in Malaysia to improve access and affordability for patients who currently have to fork out large sums of money for treatment in the country.
Kuala Lumpur – Once considered rare, autism is now on the rise and approximately 67 million worldwide live with autism. According to the Malaysian Department of Social Welfare, there are close to 13,000 individuals in Malaysia who are registered as autistic in 2014. Meanwhile, the Malaysian Ministry of Health reported that autism cases in the country are on the rise every year, emphasising the importance of early treatment to improve a child’s development.